Fig. 1From: Metastatic EML4-ALK fusion detected by circulating DNA genotyping in an EGFR-mutated NSCLC patient and successful management by adding ALK inhibitors: a case reportChanges in image during treatments. API, active pharmaceutical ingredientBack to article page